Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'mdma brain' OR with Authors including 'mdma brain' OR with Abstract including 'mdma brain' OR with Keywords including 'mdma brain'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Nichols DE, Lloyd DH, Hof... Effects of certain hallucinogenic amphetamine analogues on the release... J Med Chem 1982
Gehlert DR, Schmidt CJ, W... Evidence for specific methylenedioxymethamphetamine (ecstasy) binding ... Eur J Pharmacol 1985
Commins DL, Vosmer G, Vir... Biochemical and histological evidence that methylenedioxymethylampheta... J Pharmacol Exp Ther 1986
Johnson MP, Hoffman AJ, N... Effects of the enantiomers of MDA, MDMA and related analogues on [3H]s... Eur J Pharmacol 1986
Lyon RA, Glennon RA, Tite... 3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions... Psychopharmacology (... 1986
Schmidt CJ, Wu L, Lovenbe... Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine an... Eur J Pharmacol 1986
Stone DM, Stahl DC, Hanso... The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methyl... Eur J Pharmacol 1986
Battaglia G, Yeh SY, O'He... 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine de... J Pharmacol Exp Ther 1987
Frith CH, Chang LW, Latti... Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the ra... Fundam Appl Toxicol 1987
Gibb JW, Stone DM, Stahl ... The effects of amphetamine-like designer drugs on monoaminergic system... NIDA Res Monogr 1987
Mokler DJ, Robinson SE, R... (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reduc... Eur J Pharmacol 1987
Ricaurte GA, Finnegan KF,... 3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, pr... Eur J Pharmacol 1987
Steele TD, Nichols DE, Yi... Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and... Biochem Pharmacol 1987
Stone DM, Johnson M, Hans... A comparison of the neurotoxic potential of methylenedioxyamphetamine ... Eur J Pharmacol 1987
Stone DM, Merchant KM, Ha... Immediate and long-term effects of 3,4-methylenedioxymethamphetamine o... Neuropharmacology 1987
Wang SS, Ricaurte GA, Per... [3H]3,4-methylenedioxymethamphetamine (MDMA) interactions with brain m... Eur J Pharmacol 1987
Finnegan KT, Ricaurte GA,... Orally administered MDMA causes a long-term depletion of serotonin in ... Brain Res 1988
Battaglia G, Brooks BP, K... Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at v... Eur J Pharmacol 1988
Battaglia G, Yeh SY, de S... MDMA-induced neurotoxicity: parameters of degeneration and recovery of... Pharmacol Biochem Be... 1988
Buchanan JF, Brown CR 'Designer drugs'. A problem in clinical toxicology Med Toxicol Adverse ... 1988
Gold LH, Koob GF Methysergide potentiates the hyperactivity produced by MDMA in rats Pharmacol Biochem Be... 1988
Hubner CB, Bird M, Rassni... The threshold lowering effects of MDMA (ecstasy) on brain-stimulation ... Psychopharmacology (... 1988
Johnson M, Letter AA, Mer... Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamp... J Pharmacol Exp Ther 1988
Lim HK, Foltz RL In vivo and in vitro metabolism of 3,4-(methylenedioxy)methamphetamine... Chem Res Toxicol 1988
Nencini P, Woolverton WL,... Enhancement of morphine-induced analgesia after repeated injections of... Brain Res 1988
O'Hearn E, Battaglia G, D... Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDM... J Neurosci 1988
Ricaurte GA, DeLanney LE,... Toxic effects of MDMA on central serotonergic neurons in the primate: ... Brain Res 1988
Ricaurte GA, DeLanney LE,... 5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergi... Brain Res 1988
Ricaurte GA, Forno LS, Wi... (+/-)3,4-Methylenedioxymethamphetamine selectively damages central ser... JAMA 1988
Scallet AC, Lipe GW, Ali ... Neuropathological evaluation by combined immunohistochemistry and dege... Neurotoxicology 1988
Schmidt CJ, Taylor VL Direct central effects of acute methylenedioxymethamphetamine on serot... Eur J Pharmacol 1988
Slikker W Jr, Ali SF, Sca... Neurochemical and neurohistological alterations in the rat and monkey ... Toxicol Appl Pharmac... 1988
Yamamoto BK, Spanos LJ The acute effects of methylenedioxymethamphetamine on dopamine release... Eur J Pharmacol 1988
Wilkerson G, London ED Effects of methylenedioxymethamphetamine on local cerebral glucose uti... Neuropharmacology 1989
Battaglia G, De Souza EB Pharmacologic profile of amphetamine derivatives at various brain reco... NIDA Res Monogr 1989
De Souza EB, Battaglia G Effects of MDMA and MDA on brain serotonin neurons: evidence from neur... NIDA Res Monogr 1989
Dimpfel W, Spuler M, Nich... Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting... Psychopharmacology (... 1989
Gazzara RA, Takeda H, Cho... Inhibition of dopamine release by methylenedioxymethamphetamine is med... Eur J Pharmacol 1989
Gold LH, Geyer MA, Koob G... Psychostimulant properties of MDMA NIDA Res Monogr 1989
Gold LH, Geyer MA, Koob G... Neurochemical mechanisms involved in behavioral effects of amphetamine... NIDA Res Monogr 1989
Insel TR, Battaglia G, Jo... 3,4-Methylenedioxymethamphetamine ('ecstasy') selectively destroys bra... J Pharmacol Exp Ther 1989
Johnson M, Stone DM, Bush... Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced n... Eur J Pharmacol 1989
Kleven MS, Woolverton WL,... Evidence that both intragastric and subcutaneous administration of met... Brain Res 1989
Li AA, Marek GJ, Vosmer G... Long-term central 5-HT depletions resulting from repeated administrati... Pharmacol Biochem Be... 1989
Matthews RT, Champney TH,... Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopam... Pharmacol Biochem Be... 1989
Nichols DE, Oberlender R,... Studies of dioxole ring substituted 3,4-methylenedioxyamphetamine (MDA... Pharmacol Biochem Be... 1989
Ricaurte GA Studies of MDMA-induced neurotoxicity in nonhuman primates: a basis fo... NIDA Res Monogr 1989
Sadzot B, Baraban JM, Gle... Hallucinogenic drug interactions at human brain 5-HT2 receptors: impli... Psychopharmacology (... 1989
Slikker W Jr, Holson RR, ... Behavioral and neurochemical effects of orally administered MDMA in th... Neurotoxicology 1989
Sprouse JS, Bradberry CW,... MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal... Eur J Pharmacol 1989
Steele TD, Nichols DE, Yi... MDMA transiently alters biogenic amines and metabolites in mouse brain... Pharmacol Biochem Be... 1989
Stone DM, Hanson GR, Gibb... In vitro reactivation of rat cortical tryptophan hydroxylase following... J Neurochem 1989
Zaczek R, Hurt S, Culp S,... Characterization of brain interactions with methylenedioxyamphetamine ... NIDA Res Monogr 1989
Paulus MP, Geyer MA, Gold... Application of entropy measures derived from the ergodic theory of dyn... Proc Natl Acad Sci U... 1990
De Souza EB, Battaglia G,... Neurotoxic effect of MDMA on brain serotonin neurons: evidence from ne... Ann N Y Acad Sci 1990
Fitzgerald JL, Reid JJ Effects of methylenedioxymethamphetamine on the release of monoamines ... Eur J Pharmacol 1990
Hashimoto K, Goromaru T Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-m... Neuropharmacology 1990
Hashimoto K, Goromaru T Reduction of [3H]6-nitroquipazine-labelled 5-hydroxytryptamine uptake ... Fundam Clin Pharmaco... 1990
Hekmatpanah CR, Peroutka ... 5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-... Eur J Pharmacol 1990
Molliver ME, Berger UV, M... Neurotoxicity of MDMA and related compounds: anatomic studies Ann N Y Acad Sci 1990
Poland RE Diminished corticotropin and enhanced prolactin responses to 8-hydroxy... Neuropharmacology 1990
Scheffel U, Ricaurte GA Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamin... Brain Res 1990
Schmidt CJ, Black CK, Abb... Chloral hydrate anesthesia antagonizes the neurotoxicity of 3,4-methyl... Eur J Pharmacol 1990
Schmidt CJ, Kehne JH Neurotoxicity of MDMA: neurochemical effects Ann N Y Acad Sci 1990
Sprouse JS, Bradberry CW,... 3,4-Methylenedioxymethamphetamine-induced release of serotonin and inh... Eur J Pharmacol 1990
Teitler M, Leonhardt S, A... Receptor pharmacology of MDMA and related hallucinogens Ann N Y Acad Sci 1990
Winslow JT, Insel TR Serotonergic modulation of rat pup ultrasonic vocal development: studi... J Pharmacol Exp Ther 1990
Yousif MY, Fitzgerald RL,... Identification of metabolites of 3,4-methylenedioxymethamphetamine in ... Drug Alcohol Depend 1990
McKenna DJ, Guan XM, Shul... 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential eff... Pharmacol Biochem Be... 1991
Paris JM, Cunningham KA Lack of Neurotoxicity after Intra-Raphe Micro-Injections of MDMA ('Ecs... NIDA Res Monogr 1991
Battaglia G, Sharkey J, K... Neuroanatomic specificity and time course of alterations in rat brain ... Synapse 1991
Bradberry CW, Sprouse JS,... In vitro microdialysis: a novel technique for stimulated neurotransmit... J Neurosci Methods 1991
Champney TH, Matthews RT Pineal serotonin is resistant to depletion by serotonergic neurotoxins... J Pineal Res 1991
Dornan WA, Katz JL, Ricau... The effects of repeated administration of MDMA on the expression of se... Pharmacol Biochem Be... 1991
Gough B, Ali SF, Slikker ... Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamine... Pharmacol Biochem Be... 1991
Johnson M, Bush LG, Gibb ... Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in n... Eur J Pharmacol 1991
Lim HK, Foltz RL In vivo formation of aromatic hydroxylated metabolites of 3,4-(methyle... Biol Mass Spectrom 1991
Nash JF, Arora RC, Schrei... Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding ... Biochem Pharmacol 1991
Nash JF, Nichols DE Microdialysis studies on 3,4-methylenedioxyamphetamine and structurall... Eur J Pharmacol 1991
Nichols DE, Johnson MP, O... 5-Iodo-2-aminoindan, a nonneurotoxic analogue of p-iodoamphetamine Pharmacol Biochem Be... 1991
Pan HS, Wang RY The action of (+/-)-MDMA on medial prefrontal cortical neurons is medi... Brain Res 1991
Park WK, Azmitia EC 5-HT, MDMA (ecstasy), and nimodipine effects on 45Ca-uptake into rat b... Ann N Y Acad Sci 1991
Schechter MD Effect of serotonin depletion by p-chlorophenylalanine upon discrimina... Gen Pharmacol 1991
Schmidt CJ, Taylor VL, Ab... 5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-m... J Pharmacol Exp Ther 1991
St Omer VEV, Ali SF, Hols... Behavioral and neurochemical effects of prenatal methylenedioxymethamp... Neurotoxicol Teratol 1991
Steele TD, Brewster WK, J... Assessment of the role of alpha-methylepinine in the neurotoxicity of ... Pharmacol Biochem Be... 1991
Yeh SY, Hsu FL The neurochemical and stimulatory effects of putative metabolites of 3... Pharmacol Biochem Be... 1991
Abbott A, Concar D A trip into the unknown New Scientist 1992
Farfel GM, Vosmer GL, Sei... The N-methyl-D-aspartate antagonist MK-801 protects against serotonin ... Brain Res 1992
Glennon RA, Higgs R Investigation of MDMA-related agents in rats trained to discriminate M... Pharmacol Biochem Be... 1992
Hashimoto K, Maeda H, Gor... Effects of benzylpiperazine derivatives on the neurotoxicity of 3,4-me... Brain Res 1992
Johnson M, Elayan I, Hans... Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphet... J Pharmacol Exp Ther 1992
Lehmann J, DeSouza EB, Cu... Regional distribution to recovery of 5-HT levels after administration ... Ann N Y Acad Sci 1992
Lin LY, Kumagai Y, Cho AK Enzymatic and chemical demethylenation of (methylenedioxy)amphetamine ... Chem Res Toxicol 1992
McCann UD, Ricaurte GA MDMA ('ecstasy') and panic disorder: induction by a single dose Biol Psychiatry 1992
Paris JM, Cunningham KA Lack of serotonin neurotoxicity after intraraphe microinjection of (+)... Brain Res Bull 1992
Rezvani AH, Garges PL, Mi... Attenuation of alcohol consumption by MDMA (ecstasy) in two strains of... Pharmacol Biochem Be... 1992
Ricaurte GA, Martello AL,... Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on ce... J Pharmacol Exp Ther 1992
Schmidt CJ, Black CK, Tay... The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-... Eur J Pharmacol 1992
Steele TD, Katz JL, Ricau... Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-amin... Brain Res 1992

Page 1 of 4   /   370 Entries Returned
Pages:     
 1 
2 3 4 next